Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
PLEN 03 - Science Drives Lung Cancer Advances
- Type: Plenary
- Track: Plenary
- Presentations: 6
- Moderators:T. Mitsudomi
- Coordinates: 9/09/2015, 08:15 - 09:45, Plenary Hall (Bellco Theatre)
-
+
Introduction
08:15 - 08:20
- Abstract
No abstract available for this presentation
-
+
PLEN03.01 - Lung Cancer Genomes - Adenocarcinoma
08:20 - 08:35 | Author(s): M. Meyerson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN03.02 - Lung Cancer Genomes - Squamous Cell Carcinoma/Small Cell
08:35 - 08:50 | Author(s): R.K. Thomas
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN03.03 - Molecular Mechanisms of Drug Resistance
08:50 - 09:10 | Author(s): P.A. Jänne
- Abstract
No abstract available for this presentation
-
+
PLEN03.04 - Personalized Medicine
09:10 - 09:30 | Author(s): J. Remon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN03.05 - Mouse Models of SCLC and NSCLC
09:30 - 09:50 | Author(s): A. Berns
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PLEN 04 - Presidential Symposium Including Top 4 Abstracts
- Type: Plenary
- Track: Plenary
- Presentations: 12
- Moderators:T. Mok
- Coordinates: 9/09/2015, 10:45 - 12:15, Plenary Hall (Bellco Theatre)
-
+
Q&A
11:05 - 11:07
- Abstract
No abstract available for this presentation
-
+
Q&A
11:27 - 11:29
- Abstract
No abstract available for this presentation
-
+
Q&A
11:49 - 11:51
- Abstract
No abstract available for this presentation
-
+
Q&A
12:11 - 12:13
- Abstract
No abstract available for this presentation
-
+
PLEN04.01 - A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): SWOG S0819
10:45 - 10:57 | Author(s): R. Herbst
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.02 - Discussant for PLEN04.01
10:57 - 11:05 | Author(s): R. Pirker
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.03 - Randomized Phase III Trial of Adjuvant Chemotherapy with or without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC): Results of E1505
11:07 - 11:19 | Author(s): H.A. Wakelee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.04 - Discussant for PLEN04.03
11:19 - 11:27 | Author(s): P.A. Bunn, Jr
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.05 - Multiregion Whole Exome and Transcriptome Sequencing Defines the Genomic Spectrum of EGFR+ NSCLC and Reveals Novel Mechanisms of TKI Resistance
11:29 - 11:41 | Author(s): D.S. Tan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.06 - Discussant for PLEN04.05
11:41 - 11:49 | Author(s): R.K. Thomas
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.07 - Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography (LDCT) Screening Volunteers
11:51 - 12:03 | Author(s): U. Pastorino
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN04.08 - Discussant for PLEN04.07
12:03 - 12:11 | Author(s): N. Yamaguchi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 38 - Liquid Biopsies
- Type: Oral Session
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 8
- Moderators:M.S. Tsao
- Coordinates: 9/09/2015, 16:45 - 18:15, Mile High Ballroom 2a-3b
-
+
ORAL38.04 - Discussant for ORAL38.01, ORAL38.02, ORAL38.03
17:18 - 17:28 | Author(s): T. Mok
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 31 - ALK
- Type: Mini Oral
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 15
- Moderators:S. Malik
- Coordinates: 9/09/2015, 18:30 - 20:00, Mile High Ballroom 1a-1f
-
+
MINI31.04 - Intracranial Efficacy of First-Line Crizotinib vs. Chemotherapy in ALK-Positive NSCLC
18:45 - 18:50 | Author(s): B.J. Solomon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MINI31.12 - Quality of Life for Crizotinib vs. Chemotherapy in Asian ALK-Positive NSCLC Patients
19:35 - 19:40 | Author(s): F. Blackhall
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MINI31.13 - Symptoms and QOL with Ceritinib in ALK+ NSCLC Patients with/without Brain Metastases
19:40 - 19:45 | Author(s): L. Crinò
- Abstract
Loading... -
+
MINI31.14 - PROs with Ceritinib in ALKi-Naive ALK+ NSCLC Patients with and without Brain Metastases
19:45 - 19:50 | Author(s): K. Park
- Abstract
Loading...
first
prev